Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iovance Biotherapeutics (IOVA) Preferred Shares (2016 - 2025)

Historic Preferred Shares for Iovance Biotherapeutics (IOVA) over the last 8 years, with Q3 2025 value amounting to $2000.0.

  • Iovance Biotherapeutics' Preferred Shares changed N/A to $2000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2000.0, marking a year-over-year change of. This contributed to the annual value of $3000.0 for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, Iovance Biotherapeutics' Preferred Shares stood at $2000.0.
  • In the past 5 years, Iovance Biotherapeutics' Preferred Shares registered a high of $3000.0 during Q1 2023, and its lowest value of $2000.0 during Q1 2025.
  • In the last 3 years, Iovance Biotherapeutics' Preferred Shares had a median value of $3000.0 in 2023 and averaged $2666.7.
  • In the last 5 years, Iovance Biotherapeutics' Preferred Shares changed by 0.0% in 2024 and then tumbled by 3333.33% in 2025.
  • Quarter analysis of 3 years shows Iovance Biotherapeutics' Preferred Shares stood at $3000.0 in 2023, then changed by 0.0% to $3000.0 in 2024, then crashed by 33.33% to $2000.0 in 2025.
  • Its Preferred Shares was $2000.0 in Q3 2025, compared to $2000.0 in Q2 2025 and $2000.0 in Q1 2025.